chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 3.0
Sex: M
Vaccine: MMR
Symptoms: Eating disorder, Injection site erythema, Pyrexia
Clinical narrative: Information has been received from a consumer concerning her a 36 month old son who, "probable when he was 18 months to 2 1/2 years old", was vaccinated with one dose of MMR II. There was no concomitant medication. Within a couple of hours after vaccination, the patient experienced fever and redness on the injection site. The patient's mother noticed that the patient couldn't eat normally for 3 to 4 days. Subsequently, the patient recovered. No further information is available.
Age: 1.0
Sex: M
Vaccine: MMR
Symptoms: Measles post vaccine
Clinical narrative: Information has been received from a consumer concerning her son, a 12 month old male with allergies to formaldehyde and fragrance mix and history of sleep apnea and had tonsils and adenoids who on 10-JAN-2006 was vaccinated with MMR II. There was no concomitant medication. The patient developed the measles within 48 hours of receiving MMR II. The patient did not perform any lab diagnostics study. Subsequently, the patient recovered from the measles. The patient sought medical attention. Additional information is not expected.
Age: 1.2
Sex: F
Vaccine: MMR, PNC, VARCEL
Symptoms: Immediate post-injection reaction, Injection site urticaria, Oedema peripheral, Urticaria
Clinical narrative: Information has been received from an office manager concerning a 14 month old female who on 13-JAN-2009 was vaccinated with a dose of MMR II subcutaneously. The patient broke out in hives immediately after receiving the vaccine. The hives were all over the patient's body and closer to the injection site and the patient had larger sized welts. The patient was given ZYRTEC orally and the symptoms improved and they sent the patient home that same day. The patient sought medical attention by visiting the physician's office. Follow up information was received from a physician who reported the patient with no previous medical history and drug allergies was vaccinated intramuscularly with the first dose of MMR II (rHA, lot #659879/1083X). On the same day the patient also was vaccinated with a dose of VARIVAX (Merck) (MSD) (lot #662196/1542X) subcutaneously and a dose of PREVNAR (lot #005852) intramuscularly. At 11:00 on 13-JAN-2009 the patient experienced acute onset of edema and hives at site of arms. Patient was given 10 mg ZYRTEC oral with improvement of hives within 15 minutes. The patient recovered on 13-JAN-2009. Additional information is not expected.
Sex: F
Vaccine: MMR
Symptoms: Accidental exposure, Eye pain
Clinical narrative: Information has been received from a registered nurse who on 14-JAN-2009 was administering MMR II and some vaccine splashed into her eyes. The nurse rinsed her eyes. At the time of reporting, her eyes were "stinging". The nurse spoke to physician, and was recovering from the events. No further information is available.
Sex: U
Vaccine: IPV, MMR
Symptoms: Febrile convulsion
Clinical narrative: Information has been received from a physician concerning a patient who "several months ago" was vaccinated with a dose of MMR II (lot# not provided). Concomitant therapy included Poliovirus vaccine (manufacturer unknown). Subsequently the patient experienced a febrile seizure. Patient sought unspecified medical attention. Upon internal review, febrile seizure was determined to be an other important medical event. At the time of the report the patient had recovered. Additional information has been requested.
Age: 30.0
Sex: M
Vaccine: MMR
Symptoms: Measles antibody, Mumps antibody test, Rubella antibody negative, Rubella antibody test
Clinical narrative: Information has been received from a registered nurse concerning a 30 year old male patient with no pertinent medical history and no drug reactions or allergies who on an unknown date was vaccinated with MMR II (lot # not reported). There was no concomitant medication. The nurse reported that the patient who recently immigrated was nonreactive and nonequivocal for rubella, equivocal for mumps and reactive to rubella. The nurse stated that the patient thinks he might have received the vaccine in the past but he was not sure. The patient sought medical attention at the physician's office. Follow up information has been received from a registered nurse concerning a 30 year old male patient with no pertinent medical history and no drug reactions or allergies who on an unknown date was vaccinated with a dose of MMR II (dose, route and lot number not reported). The registered nurse reported that she did not have additional information to provide on this patient. No further information is expected. No further information is available.
Sex: M
Vaccine: MMR
Symptoms: Vomiting
Clinical narrative: Information has been received from a consumer concerning her son with reaction to all vaccines and medications he has received that contain gelatin who on 07-MAY-2001 was vaccinated with the first dose of MMR II (lot # 636662/0019L). On 19-MAY-2005 the patient was vaccinated with the second dose of MMR II (lot # 648478/0634P). The patient experienced vomiting after vaccination. Subsequently, the patient recovered from the events. The patient also experienced an adverse event on VARIVAX (Merck) (WAES#0902USA00178). Additional information has been requested.
Age: 18.0
Sex: F
Vaccine: MMR
Symptoms: Measles antibody negative
Clinical narrative: Information has been received from a medical assistant concerning an 18 year old female who in approximately 1991, "when she was 1 year of age" was vaccinated with MMR II. On 31-OCT-2008 the patient was vaccinated with MMR II. The medical assistant states the patient still has low titer for measles. The patient's titers are not low for mumps or rubella. No further information is available.
Age: 5.0
Sex: M
Vaccine: DTAP, MMR, VARCEL
Symptoms: Pruritus, Urticaria
Clinical narrative: Information has been received from a physician concerning a 5 year old male with drug reaction to flu shot a year ago who on unspecified date was vaccinated with MMR II "normal shot". Concomitant therapy included VARIVAX. Other concomitant therapy included DTaP (unspecified). In approximately December 2008 ("couple of months ago"), the patient experienced hives over his entire body and severe itching after the vaccination. After a few hours, the patient recovered. The patient sought medical attention from the physician. Additional information has been requested.
Sex: M
Vaccine: MMR
Symptoms: Mumps antibody test negative
Clinical narrative: Information has been received from a nurse practitioner concerning a now adult male who was, on unspecified date, vaccinated with 2 doses of MMR II as a child and has a negative titer for mumps. No further information is available.
Sex: M
Vaccine: MMR
Symptoms: Mumps antibody test negative
Clinical narrative: Information has been received from a nurse practitioner concerning a now 36 years old male who on unspecified dates was vaccinated with two doses of MMR II as a child. Now the patient has a negative antibody titer for mumps. The patient was seen to visit the office. Additional information has been requested.
Age: 9.0
Sex: M
Vaccine: MMR
Symptoms: Attention deficit/hyperactivity disorder, Condition aggravated, Developmental delay, Speech disorder developmental
Clinical narrative: Information has been received from a consumer concerning his 9 year old son with attention deficit disorder (ADD) diagnosed when he was very young who in approximately 2000 or 2001 was vaccinated with one dose of MMR II. There was no concomitant medication. In approximately 2000 or 2001 the patient's ADD became much worse and began to experience speech problems and many other developmental issues. At the time of reporting, the outcome was unknown. Medical attention was sought of several physicians. No further information is available.
Age: 4.0
Sex: F
Vaccine: MMR
Symptoms: Injection site rash, Lymphadenopathy, Pyrexia
Clinical narrative: Information has been received from a consumer concerning her 4 year old daughter with no medical history and drug allergies who on 19-JAN-2009 was vaccinated with 0.5 ml dose of MMR II (lot #660581/1209X). There was no concomitant medication. About a week after being vaccinated the patient experienced a swollen lymph node in her groin area and a rash at the injection site. She also experienced a fever. The patient recovered about a few days ago. No further information was provided. The patient sought unspecified medical attention. Additional information has been requested.
Age: 28.0
Sex: M
Vaccine: MMR
Symptoms: Antibody test negative
Clinical narrative: Information has been received from a nurse concerning an approximately 28 year old male student who was possibly vaccinated with MMR II and had negative titers for one of the components of MMR II. He did, however, had titers for the other two components. It was unknown which specific component was negative. The patient thought he had received one dose of MMR II but he had no documentation. Titers for measles, mumps and rubella immunity were performed. At time of the report the outcome of the patient was unknown. It was unknown if the patient sought medical attention. No further information is available.
Age: 5.0
Sex: U
Vaccine: MMR
Symptoms: Local swelling
Clinical narrative: Information has been received from a physician concerning a 5 year old patient who on an unknown date was vaccinated with the second dose of MMR II (Lot number not reported). About three months post vaccination, the patient presented with swelling on the jaw that looked like the mumps. The patient sought unspecified medical attention. Additional information has been requested.
Age: 35.0
Sex: F
Vaccine: MMR
Symptoms: Abdominal pain, Drug exposure during pregnancy, Laboratory test, Nausea, Rubella antibody negative
Clinical narrative: Information has been received from a registered nurse concerning a 35 year old female with problems with fertility and a miscarriage in July 2007 and not known drug allergies, who on 05-NOV-2008 was vaccinated with 0.5 mL dose of MMR II, subcutaneously (Lot # reported as "1815U", Lot # 659371/1815U valid for rubella virus vaccine. There was no concomitant medication. The patient received a dose of MMR II and became pregnant possibly on 14-DEC-2008. The las menstrual period was on 30-NOV-2008. The estimated delivery date is 08-SEP-2009. The patient had routine blood work and it was found that the patient was rubella non immune. The patient sought medical attention thought an office visit. Follow-up information received from the patient's obstetrician indicated that the patient was 35 year old female patient with a history of 2 previous pregnancies, 1 live birth and 1 miscarriage (15 weeks gestation). There were no birth defects in previous pregnancies. The obstetrician reported that pregnancy was confirmed by an ultrasound that showed a 7 weeks, 3 days gestation. The obstetrician reported that the patient was vaccinated 3 1/2 weeks prior to last menstrual period. The patient was prescribed with prenatal vitamins. Additional information has been requested. This is in follow-up to report(s) previously submitted on 5/29/2009. Follow up information received from a registered nurse indicated that "the patient is immune to Rubella". She stated that at the time of the initial report, the physician thought the patient was not immune to Rubella even after MMR II was given. Follow up information received from a licensed practical nurse indicated that the patient had an ultrasound during pregnancy at 20 weeks from LPM (Level II Ultrasound) which was normal. During the pregnancy the patient had oligohydramnios. It was reported that on 19-AUG-2009, at 37 weeks from LMP, the patient gave birth to a normal female infant weighing 6 pounds and 4.88 ounces. The reporter was uncertain if there were any congenital anomalies or other complications. Follow-up information was received from a physician via medical records. It was reported that the patient is a 35 year old home maker and on 05-NOV-2008 at 12:00 was vaccinated subcutaneously with a dose of rubella virus vaccine live (lot# 659371/1815U) (also reported as a dose of MMR II given on the same date). It was reported that on 03-FEB-2009, the patient presented to the physician's office for her first obstetric consult. Since LMP (30-NOV-2009), she had had mild nausea and had mild abdominal pain. On 24-FEB-2009, the patient was feeling well, less nausea and no other concerns. Additional information is not expected.
Age: 35.0
Sex: F
Vaccine: MMR
Symptoms: Ultrasound scan
Clinical narrative: Information has been received from a registered nurse concerning a 35 year old female with problems with fertility and a miscarriage in July 2007 and not known drug allergies, who on 05-NOV-2008 was vaccinated with 0.5 mL dose of MMR II, subcutaneously (Lot # reported as "1815U", Lot # 659371/1815U valid for rubella virus vaccine. There was no concomitant medication. The patient received a dose of MMR II and became pregnant possibly on 14-DEC-2008. The las menstrual period was on 30-NOV-2008. The estimated delivery date is 08-SEP-2009. The patient had routine blood work and it was found that the patient was rubella non immune. The patient sought medical attention thought an office visit. Follow-up information received from the patient's obstetrician indicated that the patient was 35 year old female patient with a history of 2 previous pregnancies, 1 live birth and 1 miscarriage (15 weeks gestation). There were no birth defects in previous pregnancies. The obstetrician reported that pregnancy was confirmed by an ultrasound that showed a 7 weeks, 3 days gestation. The obstetrician reported that the patient was vaccinated 3 1/2 weeks prior to last menstrual period. The patient was prescribed with prenatal vitamins. Additional information has been requested. This is in follow-up to report(s) previously submitted on 5/29/2009. Follow up information received from a registered nurse indicated that "the patient is immune to Rubella". She stated that at the time of the initial report, the physician thought the patient was not immune to Rubella even after MMR II was given. Follow up information received from a licensed practical nurse indicated that the patient had an ultrasound during pregnancy at 20 weeks from LPM (Level II Ultrasound) which was normal. During the pregnancy the patient had oligohydramnios. It was reported that on 19-AUG-2009, at 37 weeks from LMP, the patient gave birth to a normal female infant weighing 6 pounds and 4.88 ounces. The reporter was uncertain if there were any congenital anomalies or other complications. Follow-up information was received from a physician via medical records. It was reported that the patient is a 35 year old home maker and on 05-NOV-2008 at 12:00 was vaccinated subcutaneously with a dose of rubella virus vaccine live (lot# 659371/1815U) (also reported as a dose of MMR II given on the same date). It was reported that on 03-FEB-2009, the patient presented to the physician's office for her first obstetric consult. Since LMP (30-NOV-2009), she had had mild nausea and had mild abdominal pain. On 24-FEB-2009, the patient was feeling well, less nausea and no other concerns. Additional information is not expected.
Sex: M
Vaccine: MMR
Symptoms: Asthma
Clinical narrative: Information has been received from a consumer concerning her son who was vaccinated with MMR II. Subsequently the patient experienced severe asthma. At the time of the report the outcome of the patient was unknown. It was unknown it the patient sought medical attention. The patient's brother also had an adverse event after vaccination with MMR II (WAES # 0902USA01522). No further information is available.
Sex: F
Vaccine: MMR
Symptoms: Adverse reaction
Clinical narrative: Information has been received from a consumer concerning his daughter who was vaccinated with MMR II. The consumer reported that the patient had a "negative reaction" to vaccine. Additional information is not expected.
Sex: U
Vaccine: MMR
Symptoms: Antibody test negative, Measles antibody negative, Mumps antibody test negative, Rubella antibody negative
Clinical narrative: Information has been received from a Registered Nurse concerning a patient who was vaccinated with all three doses of MMR II. The patient's antibody response to the vaccine was negative even after getting all three doses. Unspecified medical attention was sought. Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Speech disorder developmental
Clinical narrative: Information has been received from a consumer concerning her four and a half year old son with no pertinent medical history and no known allergies or reactions who in August 2005 ("at 12 months of age"), was vaccinated with the first dose of MMR II. One week before the patient also received VARIVAX. Subsequently the patient experienced speech delay problems. Therapy with MMR II was discontinued. At the time of reporting, the patient had recovered. The patient sought unspecified medical attention. No further information is available.
Sex: M
Vaccine: MMR
Symptoms: Pyrexia, Rash
Clinical narrative: Information has been received from a consumer whose husband on an unspecified date was vaccinated with MMR II and had reactions like fever and rash. This is one of several reports from the same source. No further information is available.
Age: 1.0
Sex: U
Vaccine: DTAP, HIBV, MMR, VARCEL
Symptoms: Injection site abscess, Injection site rash, Rash maculo-papular, Rash morbilliform
Clinical narrative: Information has been received from a physician concerning an approximately 12 month old (reported as "1 year of age") patient who on approximately 06-FEB-2009 ("1 week ago") was vaccinated with MMR II. Concomitant therapy included VARIVAX and PEDVAXHIB which were vaccinated on the same day. Other concomitant therapy included DTaP (unspecified) which was also vaccinated on the same day. Subsequently, the patient experienced measles like rash and abscess (at the injection site) and maculopapular rash. On unspecified date, the patient contacted the physician. The physician stated the vaccines were not given in his office and he does not know which vaccine was given in the area that has the measles like rash and abscess. At the time of reporting, the outcome was unknown. Additional information has been requested. This is in follow-up to report(s) previously submitted on 5/29/2009. Follow up information was received via phone call. It was reported the physician did not remember the patient and did not have additional AE information. No further information was available.
Age: 2.0
Sex: M
Vaccine: MMR, RUB
Symptoms: Wrong drug administered
Clinical narrative: Information has been received from a licensed visiting nurse concerning a 30 month old male patient with a history of jaundice at 3 weeks old who on 13-FEB-2009 was vaccinated with a dose of MMR II (lot #662559/1370X) and accidentally with a dose of MERUVAX II (Lot # 18154) instead of VARIVAX (Merck). There was no concomitant medication. At the time of reporting the child was fine. Additional information has been requested.
Age: 1.3
Sex: F
Vaccine: DTAP, MMR
Symptoms: Immune system disorder, Inflammation, Injury, Nervous system disorder
Clinical narrative: Information has been viewed on the internet concerning a 15 month old female who was vaccinated with a dose of MMR II. Concomitant vaccination included a dose of DTaP (unspecified). It was reported that the patient was injured by the MMR II vaccine and DTaP vaccine (unspecified). It was stated that the patient experienced brain inflammation, immune system malfunction and CNS disorders. Attempts to verify the existence of an identifiable patient have been unsuccessful. Additional information is not expected.
Age: 28.0
Sex: F
Vaccine: MMR
Symptoms: Measles antibody negative, Mumps antibody test positive, Rubella antibody positive
Clinical narrative: Information has been received from a registered nurse concerning a 27 year old female who in 1981 was vaccinated with a first dose of MMR II, in 1997 was vaccinated with a second dose of MMR II and in 2006 was vaccinated with a third dose of MMR II. The patient has negative measles titer even after receiving 3 doses of MMR II. The patient has positive titer for rubella and mumps. No adverse effect reported. Follow up information was received. It was reported 28 year old (previously reported as 27 year old) female who was not a smoker was vaccinated with a first, second and third dose of MMR II on 10-SEP-1981, 20-JUN-1997 and 11-AUG-2006 respectively. The patient's rubeola titer was 0.98 (equiv. result). No further information was available.
Sex: M
Vaccine: MMR
Symptoms: Allergy to vaccine, Obsessive-compulsive disorder
Clinical narrative: Information has been received from a consumer concerning her now a 5 years old son who in approximately 2005 ("when he was 1 year old") was vaccinated with MMR II. The patient had what was determined by an allergist to be an "internal allergy" to the measles and mumps component of MMR II. The patient sought unspecified medical attention. The patient underwent numerous treatments and was on many medications to reverse the effects of this "allergic reaction" during past 4 years and is considered recovered now. Specific details of how the allergy manifested was not shared but consumer did mention her son displayed "OCD (obsessive compulsive disorder) habits". Specific of treatment was also not known. No further information is available.
Age: 30.0
Sex: M
Vaccine: MMR
Symptoms: Measles antibody negative, Mumps antibody test positive, Rubella antibody positive
Clinical narrative: Information has been received from a healthcare worker concerning a 30 year old male who was vaccinated with a dose of MMR II when he was a child. Subsequently the patient had a negative titer for measles. His mumps and rubella titers were normal. No further information was available. The patient was seen in the office for medical attention. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Oropharyngeal pain, Pyrexia, Rash vesicular, Varicella post vaccine
Clinical narrative: Information has been received from a registered nurse (R.N.) concerning an 8 year old male with 1 sibling who on 29-JUN-2001 was vaccinated subcutaneously in the right deltoid with a first dose of MMR II (Lot #637433/0149L). On the same day he also received a first dose of secondary suspect VARIVAX (Lot #638490/1900K) subcutaneously in the left deltoid. There was no illness at time of vaccination. "Five days prior to onset", on 02-FEB-2009, the patient experienced sore throat and fever. He was seen by a physician and was placed on therapy with ZITHROMAX. On 07-FEB-2009 the patient "broke out in pimple like rash in various spots". It was reported that the patient was seen by the physician on 09-FEB-2009 and "some lesions are already drying". The outcome of the patient was not reported. Follow-up information was received on 20-MAR-2009 from the R.N. indicating that the patient's "pimple like rash in various spots" appeared to be "chicken pox lesions". On 16-FEB-2009 the patient was seen by a doctor and his rash had gone. This is one of several reports from the same source. Additional information is not expected.
Age: 6.0
Sex: M
Vaccine: MMR
Symptoms: Abnormal behaviour
Clinical narrative: Information has been received from a consumer concerning his 6 year old son who on an unknown dates was vaccinated with both doses of MMR II. After getting the second dose of MMR II, the patient changed his behavior. No further information is available.
Age: 2.0
Sex: M
Vaccine: MMR
Symptoms: Abnormal behaviour, Crying, Emotional distress
Clinical narrative: Information has been received from a consumer, who is the uncle of the approximately 24 months old male patient with no previous medical history who reported sometime in 2006 was vaccinated with a single dose of series of MMR II. Almost two weeks after receiving the MMR II in 2006, the patient was inconsolable and cried non stop. Then after the two weeks the patient did not act the same and was quiet and reserved. The consumer reported that the patient saw different physicians and took vitamin B (manufacturer unspecified) shots that helped the patient the most. As of 18-FEB-2009, the patient's adverse events persisted. No further information is available.
Age: 1.3
Sex: M
Vaccine: MMR
Symptoms: Mumps antibody test negative
Clinical narrative: Information has been receive from a registered nurse concerning of himself a 27 year old male with sulfonamide allergy who in 1983 was vaccinated with a dose of MMR II and now had negative mumps titer. On 19-FEB-2009 the reporter received a second dose of MMR II. Follow up information has been received from a physician concerning a 27 year old male patient who on 09-AUG-1982 was vaccinated with the first dose of MMR II (Lot not reported) and on 15-JUL-1995 with the second dose of MMR II (lot not reported). Now the patient had negative mumps titer. Additional information is not expected.
Sex: M
Vaccine: MMR
Symptoms: Convulsion, Pyrexia
Clinical narrative: The consumer reported that 10 years ago, in 1999 her son had a very severe reaction. He experienced a seizure and a high fever. The consumer stated that most of her family members had this immune disorder that made them react to live vaccines that are given in combination with other live vaccines. Her son did recover and was fine. However, her physician suggested that none of her children get the combined vaccines but rather try and separate them. Upon internal review, seizure was determined to be another important medical event. This is one of several reports received from the same source. No further information is available.
Sex: U
Vaccine: MMR
Symptoms: Mumps antibody test negative
Clinical narrative: Information has been received from a health care worker concerning himself. It was reported that in 1947 the patient was vaccinated with 2 doses of MMR II as a child. It was reported that in 2008 the patient may have received 2 additional doses of MMR II as an adult. The patient stated he was recently checked for titers and he did not have detectable antibodies for mumps. No further information is available.
Age: 8.0
Sex: M
Vaccine: MMR
Symptoms: Body temperature increased, Pyrexia
Clinical narrative: Information has been received from a consumer concerning her 8 year old son who was vaccinated with a dose of MMR II. It was reported that the patient developed a fever of 105 degrees after receiving the MMR II. It is unknown if the patient sought medical attention. The patient's outcome was not reported. No further information is available.
Sex: M
Vaccine: MMR
Symptoms: Vaccination complication
Clinical narrative: Information has been received from a consumer concerning her son who on an unspecified date was vaccinated with MMR II. It was reported that her son had a "reaction" after receiving the measles virus vaccine. It is unknown if the patient sought medical attention. The patient's outcome was not reported. No further information is available.
Sex: F
Vaccine: MMR
Symptoms: Injection site erythema, Injection site induration, Pyrexia, Reaction to previous exposure to any vaccine
Clinical narrative: Information has been received from a registered nurse concerning her daughter with frequently injection site reaction after unspecified vaccination who was vaccinated with MMR II (Lot# not reported). After vaccination with MMR II, the patient experienced an injection site reaction of redness and hardness and a fever. The outcome of adverse event was unknown. It was not reported whether the patient sought medical attention. This is one of several reports receive from the same resource. Additional information has been requested.
Age: 1.2
Sex: F
Vaccine: MMR
Symptoms: Measles antibody negative
Clinical narrative: Information has been received from a licensed practical nurse concerning a female with no medical history or drug allergies who was vaccinated with the first and second doses of MMR II at her 15 months of age and 4 years of age, respectively. There was no concomitant medication. Subsequently, the now 26 year old patient had tested negative for rubeola antibody titers. The outcome was not reported. The patient sought unspecified medical attention. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: MMR
Symptoms: Measles post vaccine, Pyrexia
Clinical narrative: Information has been received from a nurse practitioner concerning a 12 month old female who on 19-FEB-2009 was vaccinated with a dose of MMR II. 4-5 days post vaccination, the patient developed a fever and measles symptoms. At the time of reporting, the patient did not recover. The patient sought unspecified medical attention. Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Gaze palsy, Hypotonia, Loss of consciousness
Clinical narrative: Information has been received from a nurse practitioner concerning a female infant with allergies to seafood and shellfish who was vaccinated with a dose of MMR II on an unspecified date. There was no concomitant medication. Subsequently the patient experienced a loss of consciousness after received MMR II. The patient's mother relayed that her daughter went limp and her eyes rolled back. Subsequently, the patient recovered fully without requiring treatment on unspecified dates. The patient sought unspecified medical attention. Additional information has been requested.
Age: 1.12
Sex: F
Vaccine: MMR, PNC, VARCEL
Symptoms: Rash macular, Rash papular
Clinical narrative: This is in follow-up to report(s) previously submitted on 5/29/2009. Information has been received from a physician and a nurse concerning a 13 month old female who on 23-FEB-2009 was vaccinated with MMR II. The same day, the patient was vaccinated with VARIVAX vaccine and PREVNAR vaccine. The patient received the three vaccines and two days ago on 04-MAR-2009, the patient developed a red macular and papular rash. At the time of this report the patient's red macular and papular rash persisted. The patient sought medical attention by phone and visit. Follow up has been received from a physician reported the biracial patient who was vaccinated with a first dose of MMR II, in her right thigh, lot number: 661444/0529X. That same day, the patient was vaccinated with her first dose of VARIVAX in her right thigh, lot number: 66020/1119X and 4th dose of PREVENAR, in her right thigh, lot number: C69205B. The pateint developed a red macular and papular rash in her extremities. On exam, the patient had red macules of the palate and red maculopapular rash on the trunk and extremiteis. Additional information is not expected.
Age: 1.2
Sex: M
Vaccine: MMR
Symptoms: Childhood disintegrative disorder, Laboratory test
Clinical narrative: Information has been received from a consumer concerning her now 4 year old son with an intolerance to gluten and a history of "GI Issues" who "when he was 15 months old" in approximately January 2006, was vaccinated with MMR II. There was no concomitant medication. "Within 48 hours after vaccination" in approximately January 2006, the patient started "losing skills" (not further specified). The patient had sought unspecified medical attention. At the time of reporting the patient was recovering from the adverse event. No further information is available. No further information is expected.
Sex: F
Vaccine: MMR
Symptoms: Oral herpes
Clinical narrative: Information has been received from a nurse practitioner concerning a female who on an unspecified date was vaccinated with a dose of MMR II (dose, route and lot number not provided). The nurse practitioner reported that the patient developed herpes simplex of the mouth after the vaccination on an unspecified date. It was not specified if the patient sought medical attention. No further information is available.
Sex: F
Vaccine: MMR
Symptoms: Adverse reaction
Clinical narrative: Information has been received from a patient concerning his wife who on an unspecified date, was vaccinated with a dose of MMR II vaccine. The reporter stated that on an unspecified date, his wife had an adverse reaction to MMR II vaccine 7 to 8 years ago. Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Feeling hot, Malaise
Clinical narrative: Information has been received from a consumer concerning her now 15 year old daughter who was vaccinated with "one dose" of a MMR II "when she was about 24 weeks old". There was no concomitant medication. Subsequently, "after getting the vaccine" the patient experienced feverish and sick. The patient mother's reported the symptoms were improve after stopped therapy and thought the combination was a little too much for a child. The patient was recovered (unspecified date). It was not specified it the patient sought medical attention. Additional information is not expected.
Age: 55.0
Sex: F
Vaccine: MMR
Symptoms: Arthralgia, Burning sensation, Hypoaesthesia, Inflammation, Limb discomfort
Clinical narrative: Information has been received from a case in litigation for WAES #0610USA022225 from a physician via medical records concerning a 55 year old female with no known allergies and history of pernicious anemia, hypothyroidism and back surgery who on an unspecified date was vaccinated with a dose of MMR II (manufacturer unknown). The patient presented to the emergency medicine department with a history of pain in the left elbow and wrist as well as the right elbow and wrist along with some numbness in the hands, as well as burning pain and tenderness. The patient stated that the symptoms started two weeks after receiving the MMR II (manufacturer unknown). The patient had a work-up with a physician and the symptoms improved somewhat with ROFECOXIB (MSD) dose, duration not reported), although was having difficulty "today" (date not specified) and this evening concerning getting comfortable enough to get some sleep. The physician reported that the patient had apparent discomfort in flexing the hands and wrists. The patient was reported to have an apparent inflammatory reaction after receiving the MMR II (manufacturer unknown). The patient was treated with PREDNISONE 40 mg PO in the EMD, tapering dose 20 mg, 10 mg and 5 mg each of the following days and then stop. The patient was given VICODIN tablets one to two tabs PO every 4 to 6 hours when needed for pain. The patient was instructed to follow-up with physician in two days if the symptoms do not improve or to return to the EMD if symptoms worsen. The patient was discharged instable condition. No further information is available.
Age: 55.0
Sex: F
Vaccine: MMR
Symptoms: Tenderness
Clinical narrative: Information has been received from a case in litigation for WAES #0610USA022225 from a physician via medical records concerning a 55 year old female with no known allergies and history of pernicious anemia, hypothyroidism and back surgery who on an unspecified date was vaccinated with a dose of MMR II (manufacturer unknown). The patient presented to the emergency medicine department with a history of pain in the left elbow and wrist as well as the right elbow and wrist along with some numbness in the hands, as well as burning pain and tenderness. The patient stated that the symptoms started two weeks after receiving the MMR II (manufacturer unknown). The patient had a work-up with a physician and the symptoms improved somewhat with ROFECOXIB (MSD) dose, duration not reported), although was having difficulty "today" (date not specified) and this evening concerning getting comfortable enough to get some sleep. The physician reported that the patient had apparent discomfort in flexing the hands and wrists. The patient was reported to have an apparent inflammatory reaction after receiving the MMR II (manufacturer unknown). The patient was treated with PREDNISONE 40 mg PO in the EMD, tapering dose 20 mg, 10 mg and 5 mg each of the following days and then stop. The patient was given VICODIN tablets one to two tabs PO every 4 to 6 hours when needed for pain. The patient was instructed to follow-up with physician in two days if the symptoms do not improve or to return to the EMD if symptoms worsen. The patient was discharged instable condition. No further information is available.
Age: 1.0
Sex: F
Vaccine: MMR
Symptoms: Eyelid margin crusting, Pruritus, Pyrexia, Sputum discoloured
Clinical narrative: Information has been received from a consumer concerning her 12 month old daughter with no pertinent medical history or drug reactions or allergies who in December 2008, was vaccinated SC with the first 0.5 ml dose of MMR II. There was no concomitant medication. In December 2008, "one week after the vaccination", the patient had "the standard reaction, just more extreme". It was reported that the patient had "crusty eyes that wouldn't open, she produce a lot of yellow mucus, she was really itchy and had a fever of 104 degrees". In December 2008, "3 weeks after the vaccination", the patient had recovered. No lab tests were done. Unspecified medical attention was sought. No further information is available.
Age: 10.0
Sex: M
Vaccine: MMR
Symptoms: Immune system disorder
Clinical narrative: Information has been received from a consumer concerning her 10 year old son who on an unspecified date was vaccinated with a dose of MMR II (Lot # not reported). It was reported that the patient had an impaired immune system after getting MMR II. It was reported that the patient had recovered at the time of the report. The patient did not seek medical attention. No further information is available.
Sex: M
Vaccine: MMR
Symptoms: Adverse reaction
Clinical narrative: Information has been received from a consumer concerning her son who on an unspecified date was vaccinated with a dose of MMR II. It was reported that the patient experienced an unspecified adverse reaction after vaccination. No additional information was provided.
Age: 5.0
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Body temperature increased, Injection site induration, Injection site mass, Injection site rash, Pyrexia
Clinical narrative: Information has been received form a consumer concerning her 5 year old daughter with no pertinent medical history and no drug reactions or allergies who in August 2005, was vaccinated with the first dose of MMR II vaccine (lot # not reported), 0.5 mL. Concomitant vaccination on the same day included VARIVAX (Merck) (MSD). In August 2005, the patient developed a lump really hard above the injection site, rash below the injection and high fever that lasted for 2 days. The patient recovered on an unspecified date. The patient sought unspecified medical attention. Additional information is not expected.
Age: 1.0
Sex: M
Vaccine: MMR
Symptoms: Mumps
Clinical narrative: Information has been received from a physician concerning a 12 month old male with no pertinent medical history and no drug reactions or allergies who on 25-FEB-2009 was vaccinated with the first dose of MMR II, albumin status rHA, (lot # not reported), 0.5 mL, subcutaneous. On 13-MAR-2009 the patient was diagnosed with right-sided mumps. The physician did not anticipate prescribing any treatment at the time of the report. The patient sought medical attention at the physician's office. The patient had not recovered. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: MMR
Symptoms: Feeling abnormal
Clinical narrative: This is in follow-up to report(s) previously submitted on 5/29/2009. Information has been received from a consumer concerning her 12 month old son who was vaccinated with a dose of MMR II. Concomitant therapy included influenza virus vaccine (unspecified) and DTAP-IPV given at the same age. After these vaccinations the patient "started to drift out of this world". The patient had not recovered. As of 16-MAR-2009 the patient was 4 years old. Additional information has been requested.
Age: 4.0
Sex: F
Vaccine: FLUX, MMR
Symptoms: Malaise, Nasopharyngitis, Speech disorder
Clinical narrative: Information has been received from a consumer concerning her daughter 4 years old who at 15 months old (2005) was vaccinated with a dose of MMR II (Lot not reported). On the same visit the patient received a dose of influenza virus vaccine (unspecified). The child is now 4 years old and had the speech abilities of a 2 year old. The child also developed a "rough cold" and was "really sick" after vaccination. At the time of reporting, 16-MAR-2009, the patient outcome was unknown. Additional information has been requested.
Age: 6.0
Sex: M
Vaccine: MMR
Symptoms: Anorexia, Antibody test negative, Body temperature increased, Diarrhoea, Disturbance in social behaviour
Clinical narrative: Information has been received from a consumer concerning her 6 year old son who on an unknown date was vaccinated with the first dose of MMR II. It was reported that after getting the measles virus vaccine the patient experienced fever of 104 degrees that lasted for 4 days, diarrhea, lost of appetite and lost of eye contact. The patient sought unspecified medical attention. At the time of reporting the patient was recovering. The patient subsequently developed antibody response negative after receiving rotavirus vaccine (WAES # 0903USA02368). No further information is available.
Age: 6.0
Sex: M
Vaccine: MMR
Symptoms: Pyrexia
Clinical narrative: Information has been received from a consumer concerning her 6 year old son who on an unknown date was vaccinated with the first dose of MMR II. It was reported that after getting the measles virus vaccine the patient experienced fever of 104 degrees that lasted for 4 days, diarrhea, lost of appetite and lost of eye contact. The patient sought unspecified medical attention. At the time of reporting the patient was recovering. The patient subsequently developed antibody response negative after receiving rotavirus vaccine (WAES # 0903USA02368). No further information is available.
Age: 37.0
Sex: F
Vaccine: MMR
Symptoms: Rubella antibody negative
Clinical narrative: Information has been received from a consumer concerning herself (a "37 year old" female) with food allergies who received MMR II series as a child. She then received a dose of MMR II in 1997 because it was required for her job. A recent rubella titer showed low levels of immunity. This titer was required because she was pregnant. At the time of reporting (17-MAR-2009) the patient was not recovered. Additional information has been requested.
Sex: M
Vaccine: MMR
Symptoms: Reaction to previous exposure to any vaccine, Urticaria
Clinical narrative: Information has been received from a physician concerning a male patient with unknown drug reactions and asthma who was vaccinated with a second dose of MMR II vaccine (lot # not reported). It was reported that the patient developed hives after the vaccination. No additional AE information was provided. It was reported that this patient also had an adverse experience following vaccination with VARIVAX (Merck) (WAES # 0903USA03185). Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Adverse reaction
Clinical narrative: Information has been received from a pharmacist concerning a patient who was vaccinated with a dose of MMR II on an unspecified date. Subsequently the patient had an unspecified reaction to MMR II. No further information is available.
Age: 0.2
Sex: U
Vaccine: MMR
Symptoms: Wrong drug administered
Clinical narrative: Information has been received from a Physician Assistant concerning an 8 week old patient who on 20-MAR-2009 was vaccinated with MMR II due to nursing error. No adverse effect was reported. Additional information has been requested.
Age: 1.2
Sex: F
Vaccine: MMR
Symptoms: Body temperature increased, Pyrexia
Clinical narrative: Information has been received from a consumer concerning her approximate 14 month old daughter with no drug allergy who on 31-MAR-1999 was vaccinated with the first dose of MMR II vaccine (lot number not provided). Subsequently the patient experienced fever over 105 degrees Fahrenheit for at least 7 days after getting MMR II vaccine. The patient was recovering. The patient did not seek medical attention. No further information is available.
Age: 1.6
Sex: F
Vaccine: MMR
Symptoms: Pyrexia
Clinical narrative: Information has been received from a consumer concerning a friend's 19 month old daughter "who went to the emergency room with a 105 degree fever 2 months ago (approximately January 2009) after receiving a dose of MMR II vaccine. Lot number is not available. It is not known if she was admitted to the hospital." The patient was recovered on an unspecified date. This is one of several reports from the same source. No further information was available.
Age: 34.0
Sex: F
Vaccine: MMR
Symptoms: Measles antibody negative
Clinical narrative: Information has been received from medical assistant concerning a 35 year old female with asthma, seasonal allergy and tetracycline and erythromycin allergies who on 28-Aug-2008 and 16-Mar-2009 was subcutaneously vaccinated with 0.5ml doses of MMR II (lot# 656426/0868U) respectively in the right arm. Concomitant therapy included Albuterol inhaler, Trazodone HCl and Veramyst nasal inhaler. Her history of  MMR II was unknown. On 16-Mar-2009 the patient had a titer drawn and was negative measles. She did not recover at time of reporting. The patient was seen for medical attention. Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Antibody test abnormal
Clinical narrative: Information has been received form a consumer via e-mail, who was vaccinated with a dose of MMR II (lot# not reported), on 5 different occasions and "did not developed sufficient antibodies". However, when she received the individual rubella postpartum, she finally developed a protective level of antibodies. No further information is available.
Age: 47.0
Sex: M
Vaccine: MMR
Symptoms: Measles antibody negative
Clinical narrative: Information has been received from a Registered Nurse concerning a 47 year old male with benign prostatic hyperplasia and no drug allergies who on 20-FEB-2009 was vaccinated subcutaneously with a 0.5 ml dose of MMR II vaccine (660202/0451X). Concomitant therapy included finasteride (MSD). The patient had a negative measles titer after receiving the vaccine. The patient sought unspecified medical attention. The result of measles titer was negative. No further information is available.
Sex: M
Vaccine: MMR
Symptoms: Social avoidant behaviour
Clinical narrative: Information has been received from a consumer concerning a male who on an unspecified date was vaccinated with a dose of MMR II (dose, route and lot number not reported). The reporter stated that "MMR may have silenced my son". It was not specified if the patient sought medical attention. No further information is available.
Age: 0.96
Sex: M
Vaccine: MMR
Symptoms: Pyrexia, Speech disorder
Clinical narrative: Information has been received from a Registered Nurse (R.N) concerning her 4 year old son with no pertinent medical history and no known drug allergies/drug reactions who was vaccinated with a dose of MMR II at one year of age (February 2006). There was no concomitant medication. It was reported that since then (approximately February 2006) the patient has required speech therapy and occupational therapy. It was reported that he also experienced a fever when he initially received the vaccine (February 2006). The patient sought unspecified medical attention. It was reported that at the time of this report (26-MAR-2009) he was "catching up" with his speech. There were no laboratory diagnostic test performed. It was reported that on an unspecified date the patient had recovered from the fever and was recovering regarding his speech. Additional information has been requested. Information has been received from a pediatric nurse on 26-MAR-2009. She reported concern with the "unavailability of the monovalents (vaccinesa)."
Sex: U
Vaccine: MMR
Symptoms: Adverse event, Pyrexia
Clinical narrative: Information has been received from a consumer concerning her child who on an unspecified date was vaccinated with a dose of MMR II. It was reported that the child "had a reaction" and had a fever following vaccination with MMR II. This is one of several cases from the same source. No further information is available.
Sex: U
Vaccine: MMR
Symptoms: Adverse reaction, Pyrexia
Clinical narrative: Information has been received from a consumer concerning her child who on an unspecified date was vaccinated with a dose of MMR II. it was reported the the child "had a reaction" and had a fever following vaccination with MMR II. This is one of several cases from the same source. No further information is available.